US Stock MarketDetailed Quotes

SLNO Soleno Therapeutics

Watchlist
  • 41.1700
  • -1.7000-3.97%
Close May 23 16:00 ET
  • 41.1700
  • 0.00000.00%
Post 16:01 ET
1.52BMarket Cap-19888P/E (TTM)

Soleno Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
182.42%23.07M
54.01%38.67M
106.52%12.83M
53.38%9.36M
34.84%8.31M
23.21%8.17M
-22.16%25.11M
-1.86%6.21M
-21.10%6.1M
-23.45%6.16M
Selling and administrative expenses
196.85%8.47M
36.95%13.48M
72.36%4.14M
42.28%3.32M
28.46%3.17M
7.98%2.85M
-8.90%9.84M
-7.47%2.4M
-15.72%2.33M
0.12%2.47M
-General and administrative expense
196.85%8.47M
36.95%13.48M
72.36%4.14M
42.28%3.32M
28.46%3.17M
7.98%2.85M
-8.90%9.84M
-7.47%2.4M
-15.72%2.33M
0.12%2.47M
Research and development costs
174.68%14.6M
65.01%25.19M
128.06%8.69M
60.25%6.04M
39.10%5.14M
33.30%5.32M
-28.84%15.27M
2.04%3.81M
-24.09%3.77M
-33.85%3.7M
Operating profit
-182.42%-23.07M
-54.01%-38.67M
-106.52%-12.83M
-53.38%-9.36M
-34.84%-8.31M
-23.21%-8.17M
22.16%-25.11M
1.86%-6.21M
21.10%-6.1M
23.45%-6.16M
Net non-operating interest income expense
1,738.05%2.08M
759.33%2.58M
1,615.20%2.14M
72.28%174K
182.69%147K
413.64%113K
172.73%300K
267.65%125K
197.06%101K
26.83%52K
Non-operating interest income
1,738.05%2.08M
759.33%2.58M
1,615.20%2.14M
72.28%174K
182.69%147K
413.64%113K
172.73%300K
267.65%125K
197.06%101K
26.83%52K
Other net income (expense)
-34.11%-401K
-490.30%-2.9M
-201.66%-611K
-1,187.69%-1.67M
49.19%-312K
-133.79%-299K
-40.11%742K
-82.67%601K
70.39%-130K
79.38%-614K
Gain on sale of security
----
-706.67%-182K
47,100.00%470K
-32,750.00%-653K
-50.00%1K
----
-94.09%30K
-100.72%-1K
-98.21%2K
-96.43%2K
Special income (charges)
-34.11%-401K
-481.18%-2.71M
-279.57%-1.08M
-673.48%-1.02M
49.19%-313K
-134.85%-299K
-2.60%712K
-81.92%602K
76.04%-132K
79.70%-616K
-Less：Restructuring and merger&acquisition
34.11%401K
481.18%2.71M
279.57%1.08M
673.48%1.02M
-49.19%313K
134.85%299K
2.60%-712K
81.92%-602K
-76.04%132K
-79.70%616K
Income before tax
-156.08%-21.4M
-62.00%-38.99M
-105.91%-11.3M
-77.12%-10.86M
-26.02%-8.48M
-45.98%-8.36M
22.14%-24.07M
-93.99%-5.49M
24.67%-6.13M
38.80%-6.73M
Income tax
Net income
-156.08%-21.4M
-62.00%-38.99M
-105.91%-11.3M
-77.12%-10.86M
-26.02%-8.48M
-45.98%-8.36M
22.14%-24.07M
-93.99%-5.49M
24.67%-6.13M
38.80%-6.73M
Net income continuous Operations
-156.08%-21.4M
-62.00%-38.99M
-105.91%-11.3M
-77.12%-10.86M
-26.02%-8.48M
-45.98%-8.36M
22.14%-24.07M
-93.99%-5.49M
24.67%-6.13M
38.80%-6.73M
Minority interest income
Net income attributable to the parent company
-156.08%-21.4M
-62.00%-38.99M
-105.91%-11.3M
-77.12%-10.86M
-26.02%-8.48M
-45.98%-8.36M
22.14%-24.07M
-93.99%-5.49M
24.67%-6.13M
38.80%-6.73M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-156.08%-21.4M
-62.00%-38.99M
-105.91%-11.3M
-77.12%-10.86M
-26.02%-8.48M
-45.98%-8.36M
22.14%-24.07M
-93.99%-5.49M
24.67%-6.13M
38.80%-6.73M
Basic earnings per share
32.95%-0.59
17.77%-2.36
38.52%-0.3566
-46.15%-0.95
-12.50%-0.81
17.76%-0.88
50.60%-2.87
-9.43%-0.58
57.52%-0.65
65.71%-0.72
Diluted earnings per share
32.95%-0.59
17.77%-2.36
38.52%-0.3566
-46.15%-0.95
-12.50%-0.81
17.76%-0.88
50.60%-2.87
-9.43%-0.58
57.52%-0.65
65.71%-0.72
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 182.42%23.07M54.01%38.67M106.52%12.83M53.38%9.36M34.84%8.31M23.21%8.17M-22.16%25.11M-1.86%6.21M-21.10%6.1M-23.45%6.16M
Selling and administrative expenses 196.85%8.47M36.95%13.48M72.36%4.14M42.28%3.32M28.46%3.17M7.98%2.85M-8.90%9.84M-7.47%2.4M-15.72%2.33M0.12%2.47M
-General and administrative expense 196.85%8.47M36.95%13.48M72.36%4.14M42.28%3.32M28.46%3.17M7.98%2.85M-8.90%9.84M-7.47%2.4M-15.72%2.33M0.12%2.47M
Research and development costs 174.68%14.6M65.01%25.19M128.06%8.69M60.25%6.04M39.10%5.14M33.30%5.32M-28.84%15.27M2.04%3.81M-24.09%3.77M-33.85%3.7M
Operating profit -182.42%-23.07M-54.01%-38.67M-106.52%-12.83M-53.38%-9.36M-34.84%-8.31M-23.21%-8.17M22.16%-25.11M1.86%-6.21M21.10%-6.1M23.45%-6.16M
Net non-operating interest income expense 1,738.05%2.08M759.33%2.58M1,615.20%2.14M72.28%174K182.69%147K413.64%113K172.73%300K267.65%125K197.06%101K26.83%52K
Non-operating interest income 1,738.05%2.08M759.33%2.58M1,615.20%2.14M72.28%174K182.69%147K413.64%113K172.73%300K267.65%125K197.06%101K26.83%52K
Other net income (expense) -34.11%-401K-490.30%-2.9M-201.66%-611K-1,187.69%-1.67M49.19%-312K-133.79%-299K-40.11%742K-82.67%601K70.39%-130K79.38%-614K
Gain on sale of security -----706.67%-182K47,100.00%470K-32,750.00%-653K-50.00%1K-----94.09%30K-100.72%-1K-98.21%2K-96.43%2K
Special income (charges) -34.11%-401K-481.18%-2.71M-279.57%-1.08M-673.48%-1.02M49.19%-313K-134.85%-299K-2.60%712K-81.92%602K76.04%-132K79.70%-616K
-Less：Restructuring and merger&acquisition 34.11%401K481.18%2.71M279.57%1.08M673.48%1.02M-49.19%313K134.85%299K2.60%-712K81.92%-602K-76.04%132K-79.70%616K
Income before tax -156.08%-21.4M-62.00%-38.99M-105.91%-11.3M-77.12%-10.86M-26.02%-8.48M-45.98%-8.36M22.14%-24.07M-93.99%-5.49M24.67%-6.13M38.80%-6.73M
Income tax
Net income -156.08%-21.4M-62.00%-38.99M-105.91%-11.3M-77.12%-10.86M-26.02%-8.48M-45.98%-8.36M22.14%-24.07M-93.99%-5.49M24.67%-6.13M38.80%-6.73M
Net income continuous Operations -156.08%-21.4M-62.00%-38.99M-105.91%-11.3M-77.12%-10.86M-26.02%-8.48M-45.98%-8.36M22.14%-24.07M-93.99%-5.49M24.67%-6.13M38.80%-6.73M
Minority interest income
Net income attributable to the parent company -156.08%-21.4M-62.00%-38.99M-105.91%-11.3M-77.12%-10.86M-26.02%-8.48M-45.98%-8.36M22.14%-24.07M-93.99%-5.49M24.67%-6.13M38.80%-6.73M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -156.08%-21.4M-62.00%-38.99M-105.91%-11.3M-77.12%-10.86M-26.02%-8.48M-45.98%-8.36M22.14%-24.07M-93.99%-5.49M24.67%-6.13M38.80%-6.73M
Basic earnings per share 32.95%-0.5917.77%-2.3638.52%-0.3566-46.15%-0.95-12.50%-0.8117.76%-0.8850.60%-2.87-9.43%-0.5857.52%-0.6565.71%-0.72
Diluted earnings per share 32.95%-0.5917.77%-2.3638.52%-0.3566-46.15%-0.95-12.50%-0.8117.76%-0.8850.60%-2.87-9.43%-0.5857.52%-0.6565.71%-0.72
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg